XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 97 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Cash flows from operating activities          
Net income (loss) attributable to common stockholders $ 6,832,172 $ (12,710,007) $ 12,050,573 $ (19,845,155)  
Adjustments to reconcile net income (loss) to net cash provided by operating activities:          
Depreciation, depletion, and amortization     2,751,533 2,769,056  
Impairment of proved property 0 15,189,459 0 24,792,079  
Stock-based compensation 329,677 317,506 527,503 617,857  
Settlement of asset retirement obligations     0 (100,389)  
Deferred income taxes     (54,278) (5,766,747)  
Net loss on derivative contracts 0 279,679 0 614,645  
Payments paid for derivative settlements     0 (2,137,225)  
Other     (4,496) 7,475  
Changes in operating assets and liabilities:          
Receivables     (4,253,003) (457,336)  
Prepaid expenses and other current assets     184,623 91,248  
Net operating loss carryback     0 (110,942)  
Accounts payable and accrued expenses     2,122,157 875,390  
Income taxes payable     568,697 (125,999)  
Net cash provided by operating activities     13,893,309 1,223,957  
Cash flows from investing activities          
Development of oil and natural gas properties     (526,275) (182,935)  
Net cash provided by (used in) investing activities     (526,275) (182,935)  
Cash flows from financing activities          
Common stock dividends paid     (5,044,789) (1,661,110) $ (79,500,000)
Common share repurchases, including shares surrendered for tax withholding     (1,599) (7,348)  
Net cash used in financing activities     (5,046,388) (1,668,458)  
Net increase (decrease) in cash and cash equivalents     8,320,646 (627,436)  
Cash and cash equivalents, beginning of period     5,276,510 19,662,528  
Cash and cash equivalents, end of period $ 13,597,156 $ 19,035,092 $ 13,597,156 $ 19,035,092 $ 13,597,156